Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-15 · accession 0001235802-23-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-17 | 2023-08-15 | XTNT | Brandt Kevin D | Chief Commercial Off | A - Grant | $0.00 | +120.5K | 824.1K | +17% | $0 |
| D | 2023-08-17 | 2023-08-15 | XTNT | Brandt Kevin D | Chief Commercial Off | F - Tax | $1.18 | -49.9K | 774.2K | -6% | -$58.9K |
| D | 2023-08-17 | 2023-08-15 | XTNT | Brandt Kevin D | Chief Commercial Off | A - Grant | $0.00 | +140.6K | 140.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | A | A | 120,499 | $0.00 | 824,070 | D | — | — | (F1) These shares will vest and be issued with respect to 30,125 shares on each of August 15, 2024, August 15, 2025 and August 15, 2026 and with respect to 30,124 shares on August 15, 2027 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. (F2) Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates. |
| 2 | Common | Common Stock | 2023-08-15 | F | D | 49,880 | $1.18 | 774,190 | D | — | — | (F2) Includes 120,499 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 412,411 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates. |
| 3 | Derivative | Stock Option (right to buy) | 2023-08-15 | A | A | 140,583 | $0.00 | 140,583 | D | $1.20 · — to 2033-08-15 | 140,583 Common Stock | (F3) This option vests with respect to 35,146 shares on August 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date. |